相关实验视频

Updated: Jul 12, 2025

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

皮肤T细胞淋巴瘤有什么新鲜事?

Sarah Morgenroth¹, Andrea Roggo¹, Laura Pawlik¹

¹Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Current oncology reports

|October 24, 2023

概括

最近皮肤T细胞淋巴瘤 (CTCL) 的进展突出了新的预后因素和治疗点. 了解瘤微环境相互作用和利用新型系统疗法为CTCL患者提供了改进的治疗策略.

科学领域:

皮肤病学皮肤病学
在瘤学瘤学.
免疫学免疫学免疫学

背景情况:

皮肤T细胞淋巴瘤 (CTCL) 是一组影响皮肤T细胞的恶性疾病.
了解瘤微环境 (TME) 和皮肤微生物群之间的复杂相互作用对于CTCL病变产生至关重要.
识别疾病进展的风险因素对于患者管理至关重要.

研究的目的:

审查皮肤T细胞淋巴瘤 (CTCL) 的预后,病原和治疗的最新更新.
突出用于管理CTCL的新治疗目标和策略.

主要方法:

审查队列研究和最近的研究发现.
对恶性细胞,TME和皮肤微生物组之间的相互作用进行分析.
评估新兴的全身疗法和治疗方式.

主要成果:

在早期CTCL中,成像可能是必要的,并且已经确定了进展的风险因素.
在TME和皮肤微生物群中的相互作用促进了对病原和瘤细胞传播的理解.
新的目标包括IL22-STAT3-CCL20级联和细胞因子 (IL-4,IL-5,IL-31) 对于.
系统疗法如JAK抑制剂,向抗体和检查点抑制剂在晚期阶段显示出有前途.
全基性造血干细胞移植提供了一个潜在的治疗方法.

结论:

需要对预后和翻译研究进行进一步的研究,以改善患者分层.
新兴的疗法和对病原学的更深入的理解为CTCL治疗提供了新的希望.
准特定的分子通路和细胞因子为干预CTCL提供了有希望的途径.

关键词:

皮肤T细胞淋巴瘤皮肤淋巴瘤是一种皮肤淋巴瘤.非黑色素瘤的皮肤癌审查 CTCL 的情况.

更多相关视频

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

相关概念视频

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.